S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Akorn Acquires Three Branded Ophthalmic Products from Merck (2013/11/15)|
|Akorn to Acquire Hi-Tech Pharmacal for $640 Million ()|
|Akorn Reports Second Quarter 2013 Financial Results ()|
|Akorn Announces Certain Preliminary Financial Results for Q3 2013 (2013/10/28)|
|Akorn Reports Third Quarter 2013 Financial Results (2013/11/5)|
|Akorn, Inc. Announces Third Quarter 2013 Earnings Release And Conference Call Information (2013/10/14)|
|Hi-Tech Pharmacal Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Acquisition by Akorn, Inc. (2013/8/27)|
|HI-TECH PHARMACAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Launches an Investigation of Hi-Tech Pharmacal Co., Inc. (HITK) Over the Proposed Sale of the Company to Akorn, Inc. (AKRX) (2013/9/13)|
|Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be Detrimental to the Interests of Hi-Tech Pharmacal Co., Inc. Shareholders (2013/9/25)|
|Acquisition of Hi-Tech Pharmacal Co., Inc. by Akorn, Inc. May Not Be in the Best Interests of Hi-Tech Pharmacal Co., Inc. Shareholders ()|
Click above to view more mutual fund data and stats for akrx - Akorn, Inc..